Accessibility: Skip TopNav
Nasdaq Welcomes Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA) to The Nasdaq Stock Market
Sienna Biopharmaceuticals CEO Frederick C. Beddingfield III, M.D., Ph.D. rings the Nasdaq Stock Market Closing Bell.
Format
JPEG
Source
Nasdaq, Inc.
Downloads
Original
Large
Medium
Small